HomeStock ScreenerSunil Healthcare

Sunil Healthcare Share Price | Sunil Healthcare Stock Screener

SUNLOC Pharmaceuticals
Share Price BSE
₹71.55
▼ -0.17 (-0.24%)
2026-07-03 00:00:00
As of July 3, 2026, the Sunil Healthcare share price (BSE: SUNLOC) is ₹71.55, down 0.24% from the previous close, with shares trading between ₹69.01 and ₹71.55, and a 52-week range of ₹59.90–₹84.88. Analyse SUNLOC share price data and track historical price performance. Use the Sunil Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Sunil Healthcare Market Cap ₹70.20 Cr.
SUNLOC P/E Ratio (TTM) 17.51
Sunil Healthcare P/B Ratio 1.33
EPS (TTM) ₹3.91
Dividend Yield -
Debt to Equity 1.27
SUNLOC 52 Week High ₹84.88
Sunil Healthcare 52 Week Low ₹59.90
Operating Margin 9.00%
Profit Margin 10.00%
SUNLOC Revenue (TTM) ₹20.00
EBITDA ₹2.00
Net Income ₹2.00
Total Assets ₹162.00
Total Equity ₹67.00

Sunil Healthcare Share Price Chart

Screen Sunil Healthcare share price with an interactive chart. Analyse SUNLOC price trends and volatility across different timeframes.

Sunil Healthcare Company Profile - Fundamental Screener

Screen Sunil Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SUNLOC shares.
Sector Healthcare
Industry Pharmaceuticals
Sub-Sector Pharmaceuticals
Segment E
ISIN INE671C01016

Sunil Healthcare Balance Sheet Screener

Screen SUNLOC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 162 159 121 110 121 130 138 142 119
Current Assets 65 63 48 35 49 59 66 69 57
Fixed Assets 94 87 70 70 70 70 69 71 60
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0
Current Liabilities 32 33 19 20 23 19 17 26 19
Non-Current Liabilities 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 67 68 56 50 44 45 47 47 43
Share Capital 10 10 10 10 10 10 10 10 10
Reserves & Surplus 57 58 46 40 34 34 37 37 33

Sunil Healthcare Income Statement Screener - Profit & Revenue Analysis

Screen Sunil Healthcare income statement and profit fundamentals. Analyze SUNLOC quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Sunil Healthcare share price evaluation.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun
Revenue 20 22 24 24 22 22 22 20 21 22 24 24 26 33 34
Expenses 18 18 19 20 18 19 19 18 18 19 22 23 23 25 26
EBITDA 2 4 4 4 4 3 2 3 3 4 2 1 3 8 8
Operating Profit % 9.00% 14.00% 14.00% 17.00% 17.00% 13.00% 10.00% 11.00% 13.00% 13.00% 4.00% 5.00% -3.00% 23.00% 22.00%
Depreciation 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2
Interest 2 2 1 1 2 2 2 2 2 1 1 1 1 1 1
Profit Before Tax -1 0 1 1 1 0 -1 -1 0 1 -1 -2 0 6 6
Tax -3 0 0 0 0 0 0 0 0 0 0 0 0 2 2
Net Profit 2 0 1 1 1 0 -1 -1 -1 0 -1 -1 0 4 4
EPS 0.57 0.35 0.89 0.97 0.57 0.15 -0.67 -0.53 -0.53 0.44 -0.63 -1.07 -0.20 3.91 4.08

Sunil Healthcare Cash Flow Screener - Liquidity Fundamentals

Screen SUNLOC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March
Operating Activities 12 -15 8 23 17 4 15 6 11
Investing Activities -8 -10 -3 -4 -11 -3 -3 -17 -13
Financing Activities -4 25 -4 -19 -6 -2 -12 11 2
Net Cash Flow 0 -1 0 0 -1 0 0 -1 0

Sunil Healthcare Shareholding Pattern Screener

See Sunil Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Sunil Healthcare promoter holding and ownership changes for SUNLOC on TickJournal.
Item 2026-Mar 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept
Promoter Holding 73.53% 73.53% 73.53% 73.53% 73.53% 73.53% 73.53% 73.53%
FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10% 0.10%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 17.84% 17.85% 17.84% 17.85% 17.85% 17.68% 17.79% 17.80%
Other Holding 8.53% 8.52% 8.52% 8.52% 8.52% 8.69% 8.58% 8.57%
Shareholder Count 6,364 6,541 6,475 6,430 6,399 6,858 6,594 6,507

Sunil Healthcare Share Dividend Screener - Share Yield Analysis

Check Sunil Healthcare dividend history with payout and yield data. View Sunil Healthcare dividend details including ex-dates and amounts for SUNLOC stock.
No dividends declared by Sunil Healthcare.

Sunil Healthcare Stock Index Membership

See which indices include Sunil Healthcare stock. Check SUNLOC index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Sunil Healthcare is not part of any tracked indices.
Only major market indices are tracked in our system.

Sunil Healthcare Market Events Screener - Corporate Actions

Get Sunil Healthcare corporate actions including splits, bonuses, and buybacks. Check Sunil Healthcare stock events that may affect SUNLOC share price.
Announcement Date Record Date Event Type Information Price Impact
Annual General Meeting NA -3.12%
Annual General Meeting NA -5.39%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 8.22%
2026-02-06 2026-02-06 Quarterly Result Announcement NA 8.65%
2025-11-04 2025-11-04 Quarterly Result Announcement NA 3.85%
2025-07-30 2025-07-30 Quarterly Result Announcement NA -1.57%
2025-05-29 2025-05-29 Quarterly Result Announcement NA -12.18%
2025-02-13 2025-02-13 Quarterly Result Announcement NA 1.99%
2024-11-13 2024-11-13 Quarterly Result Announcement NA -5.75%

Sunil Healthcare Competitors Screener - Peer Comparison

Screen SUNLOC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 449,395 39.04 58,220 6.38% 11,565 65.03
Divis Laboratories 173,802 67.84 10,560 8.73% 2,520 43.32
Torrent Pharmaceuticals 157,340 73.76 13,886 20.34% 2,138 66.05
Cipla 117,138 30.41 29,045 2.24% 3,870 68.02
Dr Reddys Laboratories 115,268 27.63 33,593 -0.44% 3,998 73.77
Zydus Life Science 113,000 22.03 26,720 13.65% 5,242 66.06
Lupin 109,763 20.55 27,488 19.98% 5,345 66.98
Mankind Pharma 102,646 52.96 14,278 12.03% 1,750 59.48
Aurobindo Pharma 88,953 25.68 33,385 3.21% 3,376 65.10
Laurus Labs 80,309 91.20 6,868 22.01% 890 70.64

Sunil Healthcare Company Announcements - News Screener

Screen SUNLOC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-07-03 Closure of Trading Window -
2026-05-31 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-30 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-29 Approved Audited Financial Results (Standalone And Consolidated) For The Quarter/Year Ended March 31 2026 -
2026-05-29 Board Meeting Outcome for Outcome Of The 269Th Board Meeting Of The Company Held On 29.05.2026. -
2026-05-29 Approved Audited Financial Results (Standalone And Consolidated) For The Quarter/Year Ended March 31 2026 -
2026-05-19 Board Meeting Intimation for Intimation Of The Board Meeting Scheduled To Be Held On 29.05.2026 Through Video Conferencing/Audio Visual Connection Pursuant To Regulation 29 Read With Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requiremen -
2026-04-24 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-16 Compliance Certificate Under Regulation 40 (10) Of SEBI LODR For The Year Ended 31St March 2026 -
2026-04-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-27 Closure of Trading Window -
2026-02-08 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-06 Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.02.2026 -
2026-02-06 Unaudited Financial Results (Both Standalone And Consolidated) For The Quarter And Nine Months Ended 31.12.2025 Of FY 2025-26 -
2026-01-28 Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (LODR) Regulations 2015 -
2026-01-07 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2025-12-29 Closure of Trading Window -
2025-11-06 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2025-11-04 Board Meeting Outcome for Outcome Of Board Meeting Held On 04.11.2025 -
2025-11-04 Unaudited Financial Results (Both Standalone And Consolidated) For The Quarter/Half Tear Ended 30.09.2025 -